Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Pharsight Corporation (NasdaqNM:PHST)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 30Price hit new 52-week low ($1.28)
Location
800 West El Camino Real, Suite 200
Mountain View, CA 94040
Phone: (650) 314-3800
Fax: (650) 314-3810
Email: info@pharsight.com
Employees (last reported count): 143
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Software & Programming
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 66%
·Over the last 6 months:
 · 2 insider buys; 15.0K shares (0.1% of insider shares)
·Institutional: 16% (46% of float)
(13 institutions)
·Net Inst. Buying: 1.86M shares (+38.87%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Pharsight Corporation develops and markets integrated products and services that help pharmaceutical and biotechnology companies improve the drug development process. The Company's solution combines proprietary computer-based simulation, statistical and data analysis tools with strategic decision making and the sciences of pharmacology, drug and disease modeling, human genetics and biostatistics. The Company's solution is designed to help its customers use a more rigorous scientific and statistical process to identify earlier those drug candidates that will not be successful and to enhance the likelihood that the remaining candidates will successfully complete clinical trials.
More from Market Guide: Expanded Business Description

Financial Summary
Pharsight Corporation develops and markets integrated products and services that help pharmaceutical companies improve the drug development process, combining computer simulation, statistical and data analysis tools with strategic decision making. For the three months ended 6/30/01, total revenues rose 11% to $2.7 million. Net loss applicable to Common rose 20% to $6.5 million. Results reflect expanded relationships with customers, offset by personnel increases.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Arthur Reidel, 49
Chairman, Pres, CEO
$200K$1.5M
Ronald Beaver, Ph.D., 35
Managing Director, Decision Services
--  --  
Robin Kehoe, 43
Sr. VP-Fin., CFO
144K1.0M
Michael Emley, 53
Sr. VP, Sales and Professional Services
197K--  
Daniel Weiner, Ph.D., 50
Sr. VP, Technology Deployment
175K--  
Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:PHSTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Aug-2001
$1.28 
Recent Price$1.795
52-Week High
on 5-Sep-2000
$11.00 
Daily Volume (3-month avg)9,591 
Daily Volume (10-day avg)7,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-83.2%
52-Week Change
relative to S&P500
-77.5%
Share-Related Items
Market Capitalization$33.2M
Shares Outstanding18.5M
Float6.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.91 
Earnings (ttm)-$1.35 
Earnings (mrq)-$0.35 
Sales (ttm)$0.74 
Cash (mrq)$0.93 
Valuation Ratios
Price/Book (mrq)1.97 
Price/EarningsN/A 
Price/Sales (ttm)2.43 
Income Statements
Sales (ttm)$12.2M
EBITDA (ttm)-$16.1M
Income available to common (ttm)-$22.1M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-79.25%
Return on Equity (ttm)-127.10%
Financial Strength
Current Ratio (mrq)3.24 
Debt/Equity (mrq)0.09 
Total Cash (mrq)$17.2M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume13.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.